Endothelin-1 inhibits apoptosis of pulmonary arterial smooth muscle in the neonatal rat

Pediatric Research

Volumn 60, Issue 3, 2006, Pages 245-251

  Jankov, Robert P ^a,b,e   Kantores, Crystal ^a   Belcastro, Rosetta ^b   Yi, Man ^b   Tanswell, A Keith ^b,c,d  

^a Sunnybrook Health Sciences Centre   (Canada)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; ENRASENTAN; PACLITAXEL; PROTEIN BAX; PROTEIN BCL XL;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTERY MUSCLE; ARTICLE; BLOOD VESSEL WALL; CONTROLLED STUDY; DRUG MECHANISM; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAT;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIN-1; FEMALE; HYPERTENSION, PULMONARY; INHIBITOR OF APOPTOSIS PROTEINS; MUSCLE, SMOOTH; OXYGEN; PULMONARY ARTERY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33747613549     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.pdr.0000233056.37254.0b     Document Type: Article

References (33)

1. Walsh MC, Stork EK 2001 Persistent pulmonary hypertension of the newborn. Rational therapy based on pathophysiology. Clin Perinatol 28:609-627
2. Jeffery TK, Wanstall JC 2001 Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension. Pharmacol Ther 92:1-20
3. Durmowicz AG, Stenmark KR 1999 Mechanisms of structural remodeling in chronic pulmonary hypertension. Pediatr Rev 20:E91-E102
4. 2 exposure enhances vascular and airway smooth muscle contraction in the newborn but not adult rat. J Appl Physiol 94:2303-2312
5. Todd L, Mullen M, Olley PM, Rabinovitch M 1985 Pulmonary toxicity of monocrotaline differs at critical periods of lung development. Pediatr Res 19:731-737
6. Ladha F, Bonnet S, Eaton F, Hashimoto K, Korbutt G, Thebaud B 2005 Sildenafil improves alveolar growth and pulmonary hypertension in hyperoxia-induced lung injury. Am J Respir Crit Care Med 172:750-756
7. Geraci MW, Moore M, Gesell T, Yeager ME, Alger L, Golpon H, Gao B, Loyd JE, Tuder RM, Voelkel NF 2001 Gene expression patterns in the lungs of patients with primary pulmonary hypertension: a gene microarray analysis. Circ Res 88:555-562
8. Jeffery TK, Morrell NW 2002 Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension. Prog Cardiovasc Dis 45:173-202
9. McMurtry MS, Bonnet S, Wu X, Dyck JR, Haromy A, Hashimoto K, Michelakis ED 2004 Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis. Circ Res 95:830-840
10. 2-induced pulmonary hypertension in the neonatal rat. Pediatr Res 50:172-183
11. Ambalavanan N, Bulger A, Murphy-Ullrich J, Oparil S, Chen YF 2005 Endothelin-A receptor blockade prevents and partially reverses neonatal hypoxic pulmonary vascular remodeling. Pediatr Res 57:631-636
12. Rosenberg AA, Kennaugh J, Koppenhafer SL, Loomis M, Chatfield BA, Abman SH 1993 Elevated immunoreactive endothelin-1 levels in newborn infants with persistent pulmonary hypertension. J Pediatr 123:109-114
13. Niu JO, Munshi UK, Siddiq MM, Parton LA 1998 Early increase in endothelin-1 in tracheal aspirates of preterm infants: correlation with bronchopulmonary dysplasia. J Pediatr 132:965-970
14. Zamora MA, Dempsey EC, Walchak SJ, Stelzner TJ 1993 BQ123, an ETA receptor antagonist, inhibits endothelin-1-mediated proliferation of human pulmonary artery smooth muscle cells. Am J Respir Cell Mol Biol 9:429-433
15. Hahn AW, Resink TJ, Scott-Burden T, Powell J, Dohi Y, Buhler FR 1990 Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function. Cell Regul 1:649-659
16. Shichiri M, Kato H, Marumo F, Hirata Y 1997 Endothelin-1 as an autocrine/paracrine apoptosis survival factor for endothelial cells. Hypertension 30:1198-1203
17. Shichiri M, Sedivy JM, Marumo F, Hirata Y 1998 Endothelin-1 is a potent survival factor for c-Myc-dependent apoptosis. Mol Endocrinol 12:172-180
18. Wu-Wong JR, Chiou WJ, Dickinson R, Opgenorth TJ 1997 Endothelin attenuates apoptosis in human smooth muscle cells. Biochem J 328:733-737
19. Dempsey EC, Badesch DB, Dobyns EL, Stenmark KR 1994 Enhanced growth capacity of neonatal pulmonary artery smooth muscle cells in vitro: dependence on cell size, time from birth, insulin-like growth factor I, and auto-activation of protein kinase C. J Cell Physiol 160:469-481
20. Jankov RP, Luo X, Cabacungan J, Belcastro R, Frndova H, Lye SJ, Tanswell AK 2000 Endothelin-1 and O2-mediated pulmonary hypertension in neonatal rats: a role for products of lipid peroxidation. Pediatr Res 48:289-298
21. Koppel R, Han RN, Cox D, Tanswell AK, Rabinovitch M 1994 α1-antitrypsin protects neonatal rats from pulmonary vascular and parenchymal effects of oxygen toxicity. Pediatr Res 36:763-770
22. Jankov RP, Kantores C, Belcastro R, Yi S, Ridsdale RA, Post M, Tanswell AK 2005 A role for platelet-derived growth factor β-receptor in a newborn rat model of endothelin-mediated pulmonary vascular remodeling. Am J Physiol Lung Cell Mol Physiol 288:L1162-L1170
23. Tanswell AK, Fraher LJ, Grose EC 1989 Circulating factors that modify lung cell DNA synthesis following exposure to inhaled oxidants. I.Effect of serum and lavage on lung fibroblasts following exposure of adult rats to 1 ppm ozone. J Toxicol Environ Health 27:239-254
24. Shirhatti V, Krishna G 1985 A simple and sensitive method for monitoring druginduced cell injury in cultured cells. Anal Biochem 147:410-418
25. Zamora MR, Stelzner TJ, Webb S, Panos RJ, Ruff LJ, Dempsey EC 1996 Overexpression of endothelin-1 and enhanced growth of pulmonary artery smooth muscle cells from fawn-hooded rats. Am J Physiol 270:L101-L109
26. Wedgwood S, Dettman RW, Black SM 2001 ET-1 stimulates pulmonary arterial smooth muscle cell proliferation via induction of reactive oxygen species. Am J Physiol Lung Cell Mol Physiol 281:L1058-L1067
27. Weissberg PL, Witchell C, Davenport AP, Hesketh TR, Metcalfe JC 1990 The endothelin peptides ET-1, ET-2, ET-3 and sarafotoxin S6b are co-mitogenic with platelet-derived growth factor for vascular smooth muscle cells. Atherosclerosis 85:257-262
28. Stenmark KR, Bouchey D, Nemenoff R, Dempsey EC, Das M 2000 Hypoxia-induced pulmonary vascular remodeling: contribution of the adventitial fibroblasts. Physiol Res 49:503-517
29. Shichiri M, Yokokura M, Marumo F, Hirata Y 2000 Endothelin-1 inhibits apoptosis of vascular smooth muscle cells induced by nitric oxide and serum deprivation via MAP kinase pathway. Arterioscler Thromb Vasc Biol 20:989-997
30. Del Bufalo D, Di Castro V, Biroccio A, Salani D, Rosano L, Spinella F, Bagnato A 2002 Endothelin-1 acts as a survival factor in ovarian carcinoma cells. Clin Sci (Lond). 103:S302-S305.
31. Dong F, Zhang X, Wold LE, Ren Q, Zhang Z, Ren J 2005 Endothelin-1 enhances oxidative stress, cell proliferation and reduces apoptosis in human umbilical vein endothelial cells: role of ETB receptor, NADPH oxidase and caveolin-1. Br J Pharmacol 145:323-333
32. Del Bufalo D, Di Castro V, Biroccio A, Varmi M, Salani D, Rosano L, Trisciuoglio D, Spinella F, Bagnato A 2002 Endothelin-1 protects ovarian carcinoma cells against paclitaxel-induced apoptosis: requirement for Akt activation. Mol Pharmacol 61:524-532
33. Srivastava RK, Srivastava AR, Korsmeyer SJ, Nesterova M, Cho-Chung YS, Longo DL 1998 Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase. Mol Cell Biol 18:3509-3517